Markets:

Overview

News

Currencies

International

Treasuries

Omnicell, Inc. - Common Stock (NQ:OMCL)

43.61 +0.31 (+0.72%)

Streaming Delayed Price Updated: 11:56 AM EDT, May 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Omnicell, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

3 Stocks Under $50 with Warning Signs

May 11, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...

Via StockStory

3 Cash-Producing Stocks We Keep Off Our Radar

May 06, 2026

A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Not...

Via StockStory

The 5 Most Interesting Analyst Questions From Omnicell’s Q1 Earnings Call

May 05, 2026

Omnicell’s first quarter was marked by strong execution and operational improvements, leading to results that exceeded Wall Street’s expectations. Management...

Via StockStory

Topics Earnings

Omnicell to Present at the BofA Securities 2026 Healthcare Conference

May 04, 2026

From Omnicell, Inc.

Via Business Wire

Omnicell Inc (NASDAQ:OMCL) Surges 12% Pre-Market After Q1 Earnings Beat and Raised Full-Year Guidance ↗

April 28, 2026

Via Chartmill

Topics Earnings

1 Small-Cap Stock to Keep an Eye On and 2 We Ignore

May 01, 2026

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...

Via StockStory

Investment Advisor Sells $6.6 Million Worth of Medical Solutions Stock, According to Recent SEC Filing ↗

April 29, 2026

Omnicell provides automation and software solutions to streamline medication management for healthcare systems and pharmacies.

Via The Motley Fool

Topics Regulatory Compliance

Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry as Senior Vice President, Chief Pharmacy and Clinical Officer

April 29, 2026

From Omnicell, Inc.

Via Business Wire

OMCL Q1 Deep Dive: Platform Expansion and Cost Controls Drive Margin Turnaround

April 29, 2026

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 14.9% year on year to $30...

Via StockStory

Topics World Trade

Why Omnicell Stock Trounced the Market on Tuesday ↗

April 28, 2026

The healthcare tech company posted strong quarterly results.

Via The Motley Fool

Omnicell (OMCL) Q1 2025 Earnings Transcript ↗

April 28, 2026

Omnicell (OMCL) Q1 2025 Earnings Transcript

Via The Motley Fool

Topics Economy World Trade

Omnicell OMCL Q2 2025 Earnings Transcript ↗

April 28, 2026

Omnicell OMCL Q2 2025 Earnings Transcript

Via The Motley Fool

Topics World Trade

Omnicell (OMCL) Q1 2026 Earnings Transcript ↗

April 28, 2026

Omnicell (OMCL) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics World Trade

Gapping stocks in Tuesday's session ↗

April 28, 2026

Via Chartmill

Top movers in Tuesday's pre-market session ↗

April 28, 2026

Via Chartmill

Omnicell’s (NASDAQ:OMCL) Q1 CY2026: Beats On Revenue

April 28, 2026

Healthcare tech company Omnicell (NASDAQ:OMCL) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 14.9% year on year to $3...

Via StockStory

Omnicell Announces First Quarter 2026 Financial Results

April 28, 2026

From Omnicell, Inc.

Via Business Wire

Omnicell (OMCL) Q1 Earnings Report Preview: What To Look For

April 26, 2026

Healthcare tech company Omnicell (NASDAQ:OMCL) will be announcing earnings results this Tuesday before market hours. Here’s what to look for. Omnicell met an...

Via StockStory

Spotting Winners: Omnicell (NASDAQ:OMCL) And Healthcare Technology for Providers Stocks In Q4

April 15, 2026

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Omnicell (NASDAQ:OMCL) and it...

Via StockStory

Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026

April 13, 2026

From Omnicell, Inc.

Via Business Wire

1 of Wall Street’s Favorite Stock with Impressive Fundamentals and 2 We Find Risky

April 10, 2026

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

Via StockStory

Topics Firearms

AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards

April 07, 2026

Via Investor Brand Network

Topics Artificial Intelligence

AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards

April 07, 2026

From AINewsWire

Via GlobeNewswire

Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know

March 27, 2026

What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...

Via StockStory

Topics Artificial Intelligence Government Stocks

3 Cash-Heavy Stocks with Warning Signs

March 24, 2026

A surplus of cash can mean financial stability, but it can also indicate a reluctance (or inability) to invest in growth. Some of these companies also face c...

Via StockStory

3 Reasons to Avoid OMCL and 1 Stock to Buy Instead

March 02, 2026

Over the past six months, Omnicell has been a great trade, beating the S&P 500 by 19.8%. Its stock price has climbed to $41.48, representing a healthy 26.4% ...

Via StockStory

Topics Stocks

3 Cash-Producing Stocks We Find Risky

February 25, 2026

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.

Via StockStory

Guardant Health, PacBio, Align Technology, QuidelOrtho, and Omnicell Shares Are Falling, What You Need To Know

February 23, 2026

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court...

Via StockStory

Topics Economy Government World Trade

The Top 5 Analyst Questions From Omnicell’s Q4 Earnings Call

February 12, 2026

Omnicell’s fourth quarter was met with a significant negative market reaction, as the company delivered revenue in line with Wall Street expectations but posted a notable shortfall in non-GAAP...

Via StockStory

Topics Earnings

OMCL Q4 Deep Dive: Product Launches, Tariff Headwinds, and Margin Pressures Shape Outlook

February 06, 2026

Healthcare tech company Omnicell (NASDAQ:OMCL) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 2.3% year on year to $314 million. The company expects next quarter’s revenue to be...

Via StockStory

Topics World Trade

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.